| Identification | |
| Name: | Tandutinib |
| Synonyms: | 1-Piperazinecarboxamide,4-[6-methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinyl]-N-[4-(1-methylethoxy)phenyl]-;CT53518;MLN 518;[4-[6-Methoxy-7-(3-piperidylpropoxy)quinazolin-4-yl]piperazinyl]-N-[4-(methylethoxy)phenyl]carboxamide; |
| CAS: | 387867-13-2 |
| Molecular Formula: | C31H42N6O4 |
| Molecular Weight: | 562.7 |
| InChI: | InChI=1/C31H42N6O4/c1-23(2)41-25-10-8-24(9-11-25)34-31(38)37-17-15-36(16-18-37)30-26-20-28(39-3)29(21-27(26)32-22-33-30)40-19-7-14-35-12-5-4-6-13-35/h8-11,20-23H,4-7,12-19H2,1-3H3,(H,34,38) |
| Molecular Structure: | ![(C31H42N6O4) 1-Piperazinecarboxamide,4-[6-methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinyl]-N-[4-(1-methyletho...](https://img.guidechem.com/casimg/387867-13-2.gif) |
| Properties | |
| Density: | 1.213 g/cm3 |
| Refractive index: | 1.61 |
| Appearance: | White Solid |
| Specification: |
Tandutinib , its cas register number is 387867-13-2. It also can be called (4-(6-Methoxy-7-(3-piperidylpropoxy)quinazolin-4-yl)piperazinyl)-N-(4-(methylethoxy)phenyl)carboxamide ; and 4-[6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide . |
| Usage: |
Tandutinib (CAS NO.387867-13-2) can be used as an oral, small-molecule inhibitor of FLT3 for the treatment of AML (acute myelogenous leukemia) and other cancer indications. |
| Safety Data | |
 |
|
